However, several studies have reported inconsistent findings regarding the correlation between EGFR mutation and decreased 18F-FDG uptake in lung cancer, with some indicating a negative association and others suggesting otherwise (Shi et al., 2022; Hong et al., 2020; Ko et al., 2014). The gene discussed is EGFR; the disease is lung carcinoma.